oops copied the wrong add

here it is

http://www.reuters.com/article/2012/05/17/idUS45973+17-May-2012+HUG20120517

Keep that research going"

I thought that was Arcapta/onbreez/indacterol????

No, it doesn't appear to be Arcapta. If I'm reading it correctly, it's Robinul, which has been around for ages for ulcers and as an antispasmodic. Which makes the study seem odd, but maybe somewhere along the way Novartis noticed some coincidence and rather advocating off-label use, they're actually doing studies. Or it could be that Google and I have not had sufficient caffeine today.

I found this. Now I'm confused. Have to look into it tomorrow I'm tuckered out:>)

http://boards.fool.co.uk/colin-an-excellent-write-up-chronic-obstructive-11071473.aspx?sort=postdate

I am reading it as one of three by Novaris:

"NVA237is expected to be one of three innovative medicines in the Novartis COPD portfolio to be delivered using the BreezhalerR Single Dose Dry Powder Inhaler, along with OnbrezR BreezhalerR (indacaterol) and investigational QVA149 (indacaterol 110 mcg/glycopyrronium bromide 50 mcg)".

NVA237 i being Glycopyrronium bromide and also one being a once a day long acting bronchodialators.

But then, I just woke up from a nap.

sure can make your head swim....

I just wanna know when I can try it out.
and if it will help or just another med to spend our money on!!!

I started the Arcapta Monday. I'll be on the look out for the others :>))